Review
doi: 10.1136/pgmj.68.795.6.
Bacterial challenges and evolving antibacterial drug strategy
Affiliations
- PMID: 1561196
- PMCID: PMC2399299
- DOI: 10.1136/pgmj.68.795.6
Item in Clipboard
Review
Bacterial challenges and evolving antibacterial drug strategy
Postgrad Med J.
1992 Jan.
No abstract available
Similar articles
-
[New antibacterial agents].Duodecim. 2000;116(24):2803-5. Duodecim. 2000. PMID: 12077883 Review. Finnish. No abstract available.
-
[Drug positioning of parenteral fluoroquinolones in management of infectious diseases. Discussion].Jpn J Antibiot. 2002 Aug;55(4):345-60. Jpn J Antibiot. 2002. PMID: 12378867 Japanese. No abstract available.
-
Metronidazole, clindamycin, and quinolones.Obstet Gynecol Clin North Am. 1989 Jun;16(2):317-28. Obstet Gynecol Clin North Am. 1989. PMID: 2674799 Review.
-
[Chlamydia trachomatis].Nihon Rinsho. 2003 Feb;61 Suppl 2:485-9. Nihon Rinsho. 2003. PMID: 12722267 Review. Japanese. No abstract available.
-
Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction.Respir Med. 2001 Jun;95 Suppl A:S2-4; discussion S26-7. doi: 10.1016/s0954-6111(01)90021-6. Respir Med. 2001. PMID: 11419670 No abstract available.
Cited by
-
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A).Antimicrob Agents Chemother. 1993 Apr;37(4):741-5. doi: 10.1128/AAC.37.4.741. Antimicrob Agents Chemother. 1993. PMID: 8494369 Free PMC article.
-
Ethiopia's Antibiotic Footprint: Employing the Newly Emerging Digital Concept to Estimate Annual Consumption for the Country.Cureus. 2023 Mar 11;15(3):e36013. doi: 10.7759/cureus.36013. eCollection 2023 Mar. Cureus. 2023. PMID: 37041906 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
